99 related articles for article (PubMed ID: 23981063)
1. Remediating cancer via splicing modulation.
Butler MS
J Med Chem; 2013 Sep; 56(17):6573-5. PubMed ID: 23981063
[TBL] [Abstract][Full Text] [Related]
2. Stabilized cyclopropane analogs of the splicing inhibitor FD-895.
Villa R; Kashyap MK; Kumar D; Kipps TJ; Castro JE; La Clair JJ; Burkart MD
J Med Chem; 2013 Sep; 56(17):6576-82. PubMed ID: 23919277
[TBL] [Abstract][Full Text] [Related]
3. An exon skipping screen identifies antitumor drugs that are potent modulators of pre-mRNA splicing, suggesting new therapeutic applications.
Shi Y; Bray W; Smith AJ; Zhou W; Calaoagan J; Lagisetti C; Sambucetti L; Crews P; Lokey RS; Webb TR
PLoS One; 2020; 15(5):e0233672. PubMed ID: 32469945
[TBL] [Abstract][Full Text] [Related]
4. Synthetic mRNA splicing modulator compounds with in vivo antitumor activity.
Lagisetti C; Pourpak A; Goronga T; Jiang Q; Cui X; Hyle J; Lahti JM; Morris SW; Webb TR
J Med Chem; 2009 Nov; 52(22):6979-90. PubMed ID: 19877647
[TBL] [Abstract][Full Text] [Related]
5. Anticancer SAR models for MCF-7 and MDA-MB-231 breast cell lines.
Qamar S; Carrasquer CA; Cunningham SL; Cunningham AR
Anticancer Res; 2011 Oct; 31(10):3247-52. PubMed ID: 21965732
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of pre-mRNA splicing by cisplatin and platinum analogs.
Schmittgen TD; Ju JF; Danenberg KD; Danenberg PV
Int J Oncol; 2003 Sep; 23(3):785-9. PubMed ID: 12888918
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationship study of arylsulfonylimidazolidinones as anticancer agents.
Sharma VK; Lee KC; Venkateswararao E; Joo C; Kim MS; Sharma N; Jung SH
Bioorg Med Chem Lett; 2011 Nov; 21(22):6829-32. PubMed ID: 21983438
[TBL] [Abstract][Full Text] [Related]
8. Anti-breast cancer activity of heteroaryl chalcone derivatives.
Solomon VR; Lee H
Biomed Pharmacother; 2012 Apr; 66(3):213-20. PubMed ID: 22440895
[TBL] [Abstract][Full Text] [Related]
9. Identification of Sansalvamide a analog potent against pancreatic cancer cell lines.
Pan PS; McGuire KL; McAlpine SR
Bioorg Med Chem Lett; 2007 Sep; 17(18):5072-7. PubMed ID: 17689077
[TBL] [Abstract][Full Text] [Related]
10. Discovery and potency optimization of 2-amino-5-arylmethyl-1,3-thiazole derivatives as potential therapeutic agents for prostate cancer.
Krasavin M; Karapetian R; Konstantinov I; Gezentsvey Y; Bukhryakov K; Godovykh E; Soldatkina O; Lavrovsky Y; Sosnov AV; Gakh AA
Arch Pharm (Weinheim); 2009 Jul; 342(7):420-7. PubMed ID: 19544302
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and SAR of C12-C13-oxazoline derivatives of epothilone A.
Pfeiffer B; Hauenstein K; Merz P; Gertsch J; Altmann KH
Bioorg Med Chem Lett; 2009 Jul; 19(14):3760-3. PubMed ID: 19433359
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationship studies of 3-aroylindoles as potent antimitotic agents.
Liou JP; Mahindroo N; Chang CW; Guo FM; Lee SW; Tan UK; Yeh TK; Kuo CC; Chang YW; Lu PH; Tung YS; Lin KT; Chang JY; Hsieh HP
ChemMedChem; 2006 Oct; 1(10):1106-18. PubMed ID: 16952120
[TBL] [Abstract][Full Text] [Related]
13. Specific inhibition of serine- and arginine-rich splicing factors phosphorylation, spliceosome assembly, and splicing by the antitumor drug NB-506.
Pilch B; Allemand E; Facompré M; Bailly C; Riou JF; Soret J; Tazi J
Cancer Res; 2001 Sep; 61(18):6876-84. PubMed ID: 11559564
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of 2-phenylthiazole-4-carboxamide derivatives as anticancer agents.
Aliabadi A; Shamsa F; Ostad SN; Emami S; Shafiee A; Davoodi J; Foroumadi A
Eur J Med Chem; 2010 Nov; 45(11):5384-9. PubMed ID: 20846760
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive study of sansalvamide A derivatives and their structure-activity relationships against drug-resistant colon cancer cell lines.
Otrubova K; Lushington G; Vander Velde D; McGuire KL; McAlpine SR
J Med Chem; 2008 Feb; 51(3):530-44. PubMed ID: 18186604
[TBL] [Abstract][Full Text] [Related]
16. SAR studies of 2-methoxyestradiol and development of its analogs as probes of anti-tumor mechanisms.
Ho A; Kim YE; Lee H; Cyrus K; Baek SH; Kim KB
Bioorg Med Chem Lett; 2006 Jul; 16(13):3383-7. PubMed ID: 16650989
[TBL] [Abstract][Full Text] [Related]
17. Discovery of novel arylethynyltriazole ribonucleosides with selective and effective antiviral and antiproliferative activity.
Wan J; Xia Y; Liu Y; Wang M; Rocchi P; Yao J; Qu F; Neyts J; Iovanna JL; Peng L
J Med Chem; 2009 Feb; 52(4):1144-55. PubMed ID: 19170598
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antiproliferative activity of novel sugiol beta-amino alcohol analogs.
Córdova I; León LG; León F; San Andrés L; Luis JG; Padrón JM
Eur J Med Chem; 2006 Nov; 41(11):1327-32. PubMed ID: 16828933
[TBL] [Abstract][Full Text] [Related]
19. Spliceostatins and Derivatives: Chemical Syntheses and Biological Properties of Potent Splicing Inhibitors.
Ghosh AK; Mishevich JL; Jurica MS
J Nat Prod; 2021 May; 84(5):1681-1706. PubMed ID: 33974423
[TBL] [Abstract][Full Text] [Related]
20. In vitro cytotoxic activity of novel protoflavone analogs - selectivity towards a multidrug resistant cancer cell line.
Danko B; Martins A; Chuang DW; Wang HC; Amaral L; Molnár J; Chang FR; Wu YC; Hunyadi A
Anticancer Res; 2012 Jul; 32(7):2863-9. PubMed ID: 22753749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
